Yahoo Web Search

Search results

  1. Indications. Treatment of single or multiple infections caused by susceptible organisms. May be used alone as first choice drug before the results of sensitivity tests are available. May be used in combination with an aminoglycoside or most other beta-lactam antibiotics.

  2. Feb 11, 2021 · Issued: London, UK. GSK has announced it has reached an agreement with Sandoz, a Novartis division, to sell its Cephalosporin antibiotics business. Sandoz will pay GSK USD 350 million at closing, plus additional milestone payments up to USD 150 million, subject to the terms of the transaction.

  3. Oct 11, 2021 · Basel, October 11, 2021 – Sandoz, a Novartis division, has successfully completed the acquisition of GSK’s cephalosporin antibiotics business. Through this transaction, Sandoz has acquired rights to three established brands (Zinnat, Zinacef and Fortum)) in more than 100 markets, further reinforcing its leading global position in antibiotics.

  4. Feb 11, 2021 · Basel, February 11, 2021 – Sandoz, a Novartis division, has signed an agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics. The agreement includes the global rights to three established brands (Zinnat ®, Zinacef ® and Fortum ®)) in more than 100 markets.

  5. Oct 11, 2021 · Basel, October 11, 2021 – Sandoz, a Novartis division, has successfully completed the acquisition of GSK’s cephalosporin antibiotics business. Through this transaction, Sandoz has acquired...

  6. Feb 11, 2021 · Basel, February 11, 2021 – Sandoz, a Novartis division, has signed an agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics. The...

  7. People also ask

  8. Feb 11, 2021 · Basel, February 11, 2021 – Sandoz, a Novartis division, has signed an agreement to acquire GSK’s cephalosporin antibiotics business, reinforcing its leading global position in antibiotics. The...

  1. People also search for